Barbara Juarez Amorim1,2,3, Angel Torrado-Carvajal2,4, Shadi A Esfahani1, Sara S Marcos5, Mark Vangel1,2,6, Dan Stein7, David Groshar7, Onofrio A Catalano8,9,10. 1. Department of Radiology, Massachusetts General Hospital, Harvard Medical School, 55 Fruit Street, White 270, Boston, MA, 02114, USA. 2. Athinoula A Martinos Center for Biomedical Imaging, Department of Radiology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA. 3. Division of Nuclear Medicine, State University of Campinas (UNICAMP), Campinas, Brazil. 4. Medical Image Analysis and Biometry Laboratory, Universidad Rey Juan Carlos, Madrid, Spain. 5. Division of Nuclear Medicine, Puerta de Hierro, University Hospital, Madrid, Spain. 6. Biostatistics Center, Massachusetts General Hospital, Harvard Medical School, Boston, USA. 7. Department of Nuclear Medicine, Assuta Medical Centers, Tel Aviv, and Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel. 8. Department of Radiology, Massachusetts General Hospital, Harvard Medical School, 55 Fruit Street, White 270, Boston, MA, 02114, USA. ocatalano@mgh.harvard.edu. 9. Athinoula A Martinos Center for Biomedical Imaging, Department of Radiology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA. ocatalano@mgh.harvard.edu. 10. Department of Radiology, University of Naples "Parthenope", Naples, Italy. ocatalano@mgh.harvard.edu.
Abstract
PURPOSE: The aim of this study was to explore possible correlations among different imaging features from 2-deoxy-2-[18F]fluoro-D-Glucose positron emission tomography/magnetic resonance imaging (PET/MRI) in rectal cancer (RC). PROCEDURES: RC patients who underwent PET/MRI were enrolled. A region of interest (ROI) was drawn around each primary RC on PET/MRI images (PET, pelvic axial T2w, and apparent diffusion coefficient maps (ADC)). Multiple imaging features were assessed, and Pearson's correlation was used to explore possible correlations among them. RESULTS: A total of 13 patients were included, mean age 56.1 years old, 6 females. A strong inverse correlation was observed between SUVpeak and ADCmean values, MTV and T2 sphericity, MTV and ADC sphericity, MTV and T2 entropy, and TLG and ADC sphericity. There was also strong direct correlation between PET entropy and ADC sphericity. CONCLUSIONS: In conclusion, several clinically relevant correlations were observed between PET and MRI imaging features. These findings show how the use of both modalities provides complementary information.
PURPOSE: The aim of this study was to explore possible correlations among different imaging features from 2-deoxy-2-[18F]fluoro-D-Glucose positron emission tomography/magnetic resonance imaging (PET/MRI) in rectal cancer (RC). PROCEDURES: RC patients who underwent PET/MRI were enrolled. A region of interest (ROI) was drawn around each primary RC on PET/MRI images (PET, pelvic axial T2w, and apparent diffusion coefficient maps (ADC)). Multiple imaging features were assessed, and Pearson's correlation was used to explore possible correlations among them. RESULTS: A total of 13 patients were included, mean age 56.1 years old, 6 females. A strong inverse correlation was observed between SUVpeak and ADCmean values, MTV and T2 sphericity, MTV and ADC sphericity, MTV and T2 entropy, and TLG and ADC sphericity. There was also strong direct correlation between PET entropy and ADC sphericity. CONCLUSIONS: In conclusion, several clinically relevant correlations were observed between PET and MRI imaging features. These findings show how the use of both modalities provides complementary information.
Entities:
Keywords:
FDG; Imaging features; PET/MRI; Rectal cancer
Authors: Barbara J Amorim; Theodore S Hong; Lawrence S Blaszkowsky; Cristina R Ferrone; David L Berger; Liliana G Bordeianou; Rocco Ricciardi; Jeffrey W Clark; David P Ryan; Jennifer Y Wo; Motaz Qadan; Mark Vangel; Lale Umutlu; David Groshar; Lina G Cañamaques; Debra A Gervais; Umar Mahmood; Bruce R Rosen; Onofrio A Catalano Journal: Eur J Nucl Med Mol Imaging Date: 2019-07-29 Impact factor: 9.236
Authors: Pierre Lovinfosse; Marc Polus; Daniel Van Daele; Philippe Martinive; Frédéric Daenen; Mathieu Hatt; Dimitris Visvikis; Benjamin Koopmansch; Frédéric Lambert; Carla Coimbra; Laurence Seidel; Adelin Albert; Philippe Delvenne; Roland Hustinx Journal: Eur J Nucl Med Mol Imaging Date: 2017-10-18 Impact factor: 9.236
Authors: C Brendle; N F Schwenzer; H Rempp; H Schmidt; C Pfannenberg; C la Fougère; K Nikolaou; C Schraml Journal: Eur J Nucl Med Mol Imaging Date: 2015-07-31 Impact factor: 9.236
Authors: E J van Helden; Y J L Vacher; W N van Wieringen; F H P van Velden; H M W Verheul; O S Hoekstra; R Boellaard; C W Menke-van der Houven van Oordt Journal: Eur J Nucl Med Mol Imaging Date: 2018-08-09 Impact factor: 9.236
Authors: Marcelo A Queiroz; Cinthia D Ortega; Felipe R Ferreira; Fernanda C Capareli; Sergio C Nahas; Giovanni G Cerri; Carlos A Buchpiguel Journal: Mol Imaging Biol Date: 2021-11-09 Impact factor: 3.488